Vima Therapeutics
Clinical trials sponsored by Vima Therapeutics, explained in plain language.
-
New daily pill targets root cause of debilitating muscle disorder
Disease control Recruiting nowThis study is testing a new oral medication called VIM0423 for people with isolated dystonia, a movement disorder that causes painful, twisting muscle contractions. About 100 adults will take either the study drug or a placebo pill daily for 16 weeks to see if it safely reduces s…
Phase: PHASE2 • Sponsor: Vima Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Scientists launch major effort to map the Real-World impact of dystonia
Knowledge-focused Recruiting nowThis study aims to better understand how isolated dystonia that affects multiple body areas impacts people's daily lives and changes over time. Researchers will follow 200 participants, aged 12-65, to collect detailed information on symptoms, disability, pain, and quality of life…
Sponsor: Vima Therapeutics • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC